伤寒Vi多糖菌苗多糖含量及分子大小测定试验

伤寒Ｖｉ多糖菌苗是我国新近研制成功的一种多糖菌苗。为了严格控制该制品的质量,经反复试验,建立了多糖含量和分子大小的测定方法。本文报导了（１）用火箭电泳法测定伤寒Ｖｉ多糖菌苗多糖含量。经对不同实验条件进行比较,选择出较为理想的条件。用该法测定８批样品。结果均符合规程要求。对其中５批样品进行６次重复试验表明,该法的重复性好,操作简单,是测定多糖含量较为理想的方法。（２）用琼脂糖柱层析法对２８批伤寒Ｖｉ多糖菌苗的分子大小进行测定。对用该法所得柱层析收集液分别用Ｈｅｓｔｒｉｎ法和２０６ｎｍ扫描法测定其多糖回收率,对测定结果进行比较。结果表明,两种方法的测定结果无显著性差异（Ｐ＞０．０１）,而且重复性均好。可根据实验室条件选择测定方法。     

伤寒Vi多糖菌苗接种反应观察

本文报告了对我国首次成功的伤寒Ｖｉ多糖菌苗进行人体接种反应观察结果,接种对象为２０至５４岁无伤寒病史,近年无伤寒菌苗接种史的健康人,共６０名,以完全随机的方法分为两组,实验组注射３０μｇＶｉ多糖菌苗,对照组注射Ｖｉ多糖菌苗的稀释液。其结果３０名Ｖｉ多糖菌苗接种者注射后体温无中重反应发生,局部红肿仅有１例中反应。注射后对血压、心律没有影响。红细胞计数,白细胞计数均在正常范围,与接种前相比,无显著差异     

伤寒Vi多糖菌苗免疫血清的LPS抗体测定

以肠炎沙门氏菌脂多糖为抗原,用酶标法测定Ｖｉ多糖菌苗免疫血清的抗ＬＰＳ抗体。各Ｖｉ多糖菌苗组免疫后１月,６月的抗ＬＰＳ水平均显著高于免前（Ｐ＜０．０００１）,对照组无显著差异（ｐ＞０．１）。两３０μｇ菌苗组抗ＬＰＳ阳转率均约为１５％。提纯Ｖｉ多糖菌苗所含的微量伤寒ＬＰＳ,也可能为接种者提供一定的保护作用。     

伤寒Vi多糖菌稳定性研究

为研究国产伤寒Vi多糖菌苗的稳定性,将保存三年以上的伤寒Vi多糖菌苗成品采用自然风干和37℃恒温干燥两种方法浓缩后,用CL－4B柱层析分析系统,测定KD在0．25前多糖的回收率,结果均大于50％,同时对保存三年以上的制品按规程进行了全球,结果均符合规程要求,表明国产菌苗放置三年依然合格。     

十六烷基三甲基溴化铵(Cetavlon)对伤寒Vi多糖菌苗生产中复合多糖收量的影响

用Ｃｅｔａｖｌｏｎ不同母液浓度、不同作用温度及作用时间等三方面对伤寒Ｖｉ多糖菌苗生产中复合多糖收量的影响进行了比较试验,结果证明,使用０．６％的浓度,１５～２０℃室温,作用１２小时以上可得到比较多的复合多糖收量。     

被动血凝试验测定伤寒Vi抗体

作者从拘橼酸杆菌中提取纯化获得其Ｖｉ多糖抗原,该抗原具有伤寒沙门氏菌Ｖｉ抗原的免疫学特性,而不含伤寒沙门氏菌０,Ｈ抗原,用其致敏新鲜羊血球作被动血凝试验,特异性敏感性均很好。所需Ｖｉ抗原致敏浓度极低,仅为０．０５ｕｇ／ｍｌ。使用新鲜羊血球凝模式较好,便于观察结果,采用被动血凝试验检测１０６名健康中学生肌肉注射３０ｕｇ伤寒Ｖｉ多糖菌苗前后Ｖｉ抗体的变化情况,发现免疫后血清抗体的四倍增长率达８９％,表明伤寒Ｖｉ多糖苗具有良好的免疫原性。     

十六烷基三甲基溴化铵（Cetavlon）对伤寒Vi多糖菌苗生产中…

用Ｃｅｔａｖｌｏｎ不同母液浓度,不同作用温度及作用时间等三方面对伤寒Ｖｉ多糖菌苗生产中复合多糖收量的影响进行了比较试验。结果证明,使用０．６％的浓度,１５－２０℃室温,作用１２小时以上可得到比较多的复合多糖收量。     

C群流脑多糖菌苗唾液酸含量测定试验

Ｃ群脑膜炎球菌多糖菌苗是我们近年开发的一种新制品,其中唾液酸（ＳＡ）是该制品的有效成份之一。为了严格控制该制品的质量,经反复试验,对比各种试验条件,选择出较理想的测定ＳＡ方法－改良法,该法与Ｓｖｅｎｎｅｒｈｏｌｍ氏法比较,其标准曲线变异系数（ｃｖ％）为０．０３％,低于Ｓｖｅｎｎｅｒｈｏｌｍ氏法（０．３１％）;其回收率平均为１００．６２％。与中检所方法比较,无显著差异（Ｐ〉０．０５）,对批样品进行６     

伤寒─鼠伤寒重组株Vi4072的效力试验研究

伤寒─鼠伤寒重组株Ｖｉ４０７２所产生Ｖｉ抗原以伤寒Ｔｙ２株所产Ｖｉ抗原作对照,通过ＥＤ５０测定和小白鼠被动保护试验作了比较,结果表明Ｖｉ４０７２株Ｖｉ抗原的半数有效剂量为０．０１３６μｇ,Ｔｙ２株的半数有效剂量为０．０１８３μｇ,说明Ｖｉ４０７２─Ｖｉ对小白鼠的保护作用不低于Ｔｙ２─Ｖｉ。被动保护试验证明,在同等条件下,两种Ｖｉ抗原的免疫血清对小白鼠提供的保护作用相同。     

伤寒─鼠伤寒重组株Vi4072的效力试验研究

伤寒─鼠伤寒重组株Ｖｉ４０７２所产生Ｖｉ抗原以伤寒Ｔｙ２株所产Ｖｉ抗原作对照,通过ＥＤ５０测定和小白鼠被动保护试验作了比较,结果表明Ｖｉ４０７２株Ｖｉ抗原的半数有效剂量为０．０１３６μｇ,Ｔｙ２株的半数有效剂量为０．０１８３μｇ,说明Ｖｉ４０７２─Ｖｉ对小白鼠的保护作用不低于Ｔｙ２─Ｖｉ。被动保护试验证明,在同等条件下,两种Ｖｉ抗原的免疫血清对小白鼠提供的保护作用相同。     

Release of Vi antigens from Salmonella typhi: implications for virulence and diagnosis

The release of Vi antigens from three clinical isolates of Salmonella typhi was measured by a Vi-specific monoclonal antibody. Large quantities of Vi antigens were detected in the culture supernates from all three strains using either passive latex agglutination or rocket immunoelectrophoresis. Vi antigens were also detected in broth cultures of S. typhi containing about 10(5) cells/ml using the sandwich enzyme linked immunosorbent assay. The significance of this finding in relationship to the virulence and the diagnosis of S. typhi was discussed.     

Release of Vi antigens from Salmonella typhi: implications for virulence and diagnosis

Abstract The release of Vi antigens from three clinical isolates of Salmonella typhi was measured by a Vi-specific monoclonal antibody. Large quantities of Vi antigens were detected in the culture supernates from all three strains using either passive latex agglutination or rocket immunoelectrophoresis. Vi antigens were also detected in broth cultures of S. typhi containing about 10⁵ cells/ml using the sandwich enzyme linked immunosorbent assay. The significance of this finding in relationship to the virulence and the diagnosis of S. typhi was discussed.     

Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.

A conjugate vaccine against Salmonella typhi was prepared by covalently binding capsular polysaccharide (Vi) with porin, both isolated from S. typhi. First, Vi and porins were extracted. The Vi was purified from S. typhi Ty2. The purified Vi conformed to the requirements of the World Health Organization. Porins were purified from S. typhi 0901. The Vi was bound to the porins by a heterobifunctional cross-linking reagent, N-succinimidyl-3-(2-pyridyl dithio)-propionate (SPDP). After preparing the Vi-porin conjugate, its protective ability and immunogenicity were studied in mice following systemic immunization. The results showed that the conjugate is 6.5-fold more protective than Vi alone against S. typhi. The mice immunized with conjugate elicited higher anti-Vi antibody (IgG) levels (P < 0.01) than the mice immunized with Vi alone. Anti-porin antibodies were also induced by the conjugate. To study the mucosal immune responses, secretory IgA (sIgA) in the intestinal fluid was measured. Conjugate-immunized mice showed the induction of sIgA as compared to Vi alone. The results showed that when Vi is bound to porins, both isolated from same organism, the resultant conjugate induced both systemic and mucosal immune responses and provided better protection against S. typhi than Vi alone.     

Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi.

Plasmid pGBM124, which contains a 14-kb Salmonella typhi chromosomal DNA fragment capable of producing the Vi antigen in Escherichia coli HB101 and ViaB-deleted S. typhi GIFU 10007-3, was studied. We determined the complete nucleotide sequence of this fragment and found 11 open reading frames. Mutagenesis, subcloning, and complementation analysis showed that three genes (vipA, vipB, and vipC) are involved in biosynthesis of the Vi polysaccharide. The putative primary amino acid sequence suggests that both vipA and vipB encode the NAD- or NADP-dependent enzymes to synthesize the nucleotide sugar for the Vi polysaccharide. Five genes (vexA, vexB, vexC, vexD, and vexE) may be involved in translocation of the Vi polysaccharide. Proteins VexA, VexB, VexC, and VexD had moderate similarities to components of group II capsule transporters, and the VexC protein had a putative ATP-binding site. These data indicate that the transport system for the Vi polysaccharide belongs to the ATP-binding cassette transporters. By using the isogenic Vi+ and Vi- strains constructed in this study, we reconfirmed that the Vi antigen is necessary for the serum resistance of S. typhi.     

Molecular cloning of the ViaB region of Salmonella typhi

The ViaB region required for Vi antigen production in Salmonella typhi was cloned. The plasmid pGBM124 containing a 14-kb S. typhi chromosomal DNA fragment conferred the ability to produce Vi antigen on Escherichia coli HB101 and ViaB-deleted S. typhi GIFU10007-3. Tn5 insertion analysis showed that the 14-kb DNA was split into three regions. Region 1 and region 2 are involved in the biosynthesis of Vi polysaccharide. Region 3 is involved in translocation of the Vi polysaccharide to the cell surface. Southern blot hybridization showed that regions 2 and 3 but not region 1, were considerably homologous to the DNA of Vi-positive Citrobacter freundii.     

The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus.

Strains of Salmonella typhi isolated from the blood of patients with typhoid fever invariably express a capsular polysaccharide, termed the Vi antigen. Vi antigen expression is controlled by two separate chromosomal loci, viaA and viaB. The viaA locus is commonly found in enteric bacteria. In contrast, the viaB locus appears to be specific to Vi-expressing strains of Salmonella and Citrobacter. Here the cloning, expression and analysis of viaB determinants from S. typhi Ty2 is described. Whole-cell DNA from strain Ty2 was size-fractionated and cloned into the pLA2917 cosmid vector. A recombinant cosmid, pVT1, conferring a Vi-positive phenotype upon Escherichia coli and upon the Vi-non-expressing strain Ty21a of S. typhi, was characterized and used for further studies. Transposon Tn5 insertion mutagenesis demonstrated that the Vi-antigen-encoding region on pVT1 consisted of a 15 kb fragment. A subclone, designated pVT3, which contained an 18 kb insert, was sufficient to confer Vi antigen expression upon E. coli and S. typhi Ty21a. Results of recombination experiments indicated that this DNA sequence was the viaB locus of S. typhi Ty2. In E. coli SE5000 maxicells, the viaB determinants encoded at least eight polypeptides, with molecular masses of 80, 65, 59, 48, 44, 39, 35 and 28 kDa. Functional characterization of viaB mutations in S. typhi Ty2 suggested that the 80 and 65 kDa proteins were required for cell-surface localization of the Vi antigen.     

肠毒素源性定居因子CS6在减素伤寒沙门氏菌中表达及免疫原性的研究

将编码肠毒素源性大肠杆菌定居因子抗原ＣＳ６基因克隆到ｐＸＬ６７０,转化ａｓｄ基因突变的Ｅ．ｃｏｌｉ Ｘ６０９７,获得重组质粒ｐＳＳ６４,再将后者转化至减毒的△ａｒｏＡ、△ａｒｏＣ、△ａｓｄ伤寒沙门氏菌,构建了无药物抗性且稳定的大肠杆菌和伤寒双价菌苗候选株。小鼠腹腔免疫和攻击实验表明,该菌株对伤寒沙门氏菌毒株的攻击具有良好的保护作用。家兔免疫实验证明,该菌株能产生抗ＣＳ６和伤寒菌Ｖｉ抗原的血清抗体。     

Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by enzyme immunoassay.

Immunisation with capsular Vi polysaccharide (Vi PS) of Salmonella enterica serovar Typhi (S. typhi) protects against typhoid. This protection depends on the presence of O-acetyl groups on the Vi PS, which form an immunodominant epitope. An antiserum raised against conjugated Vi PS was used as the basis for an indirect Enzyme Immunoassay (EIA). The antiserum did not react with lipopolysaccharide of five gram negative bacteria including S. typhi. Vi PS from three different sources was tested, and all but one of 18 native Vi PS preparations had EIA values comparable to a standard Vi PS preparation. The sensitivity of the EIA for the detection of O-acetyl groups on Vi PS was compared to an NMR spectroscopy assay (Biologicals 28 (2000) 17-24). The EIA distinguished between O-acetylated and de-O-acetylated Vi PS preparations. However, significantly lower EIA reactivity was observed only for samples which had O-acetylation levels of 25% or less. This assay should facilitate batch control of Vi vaccines.